The DOI matches its Crossref record.
Post–COVID-19 Cholangiopathy: A Novel Entity
Open accessAbstract
Introduction: Liver chemistry abnormalities are a frequent manifestation of coronavirus disease 2019 (COVID-19) but are usually transient and resolve with disease resolution. Methods: We describe the clinical course and histologic features of 3 adults who developed prolonged and severe cholestasis during recovery from critical cardiopulmonary COVID-19. Results: These patients had clinical and histologic features similar to secondary sclerosing cholangitis of the critically ill patient, but with unique histologic features including severe cholangiocyte injury and intrahepatic microangiopathy suggestive of direct hepatic injury from COVID-19. DISCUSSION: We believe that these cases constitute a novel severe post–COVID-19 cholangiopathy with potential for long-term hepatic morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Frequency, signs and symptoms, and criteria adopted for long COVID‐19: A systematic review
Cabrera Martimbianco, A. L., Pacheco, R. L., Bagattini, Â. M., & Riera, R. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14357 · Cited by 346
Parotto, M., Gyöngyösi, M., Howe, K., Myatra, S. N., Ranzani, O., Shankar-Hari, M., & Herridge, M. S. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00239-4 · Cited by 263
Cholangiokines: undervalued modulators in the hepatic microenvironment
Cai, X., Tacke, F., Guillot, A., & Liu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192840 · Cited by 40
Metadata
- Authors
- Roth, N. C., Kim, A., Vitkovski, T., Xia, J., Ramirez, G., Bernstein, D., & Crawford, J. M.
- Venue
- American Journal of Gastroenterology
- Published
- 2021-01-14
- Volume
- 116
- Issue
- 5
- Pages
- 1077-1082
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W3124428981
- Cited by
- 198
- References
- 0
- FWCI
- 13.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Post–COVID-19 Cholangiopathy: A Novel Entity. https://app.cochat.ai/papers/10.14309/ajg.0000000000001154
- The paper
- Roth, N. C., Kim, A., Vitkovski, T., Xia, J., Ramirez, G., Bernstein, D., & Crawford, J. M. (2021). Post–COVID-19 Cholangiopathy: A Novel Entity. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000001154
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.